Chronolife is developing a unique solution capable of constant monitoring of multiple physiological parameters simultaneously that makes predictions based on big data analysis in real time. Thanks to its disruptive proprietary algorithm, named HOTS (Hierarchy of Event Based Time Surfaces), Chronolife aims to create a paradigm shift in the management of patients with chronic conditions. The company has chosen to initially target two major indications that affect a large number of patients worldwide: Heart Failure and Epilepsy.